Evidence that blood–CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen

OBJECTIVE: Our objective is to explore whether blood–cerebrospinal fluid (CSF) barrier biomarkers differ in episodic migraine (EM) or chronic migraine (CM) from controls. BACKGROUND: Reports of blood–brain barrier and blood–cerebrospinal fluid barrier (BCSFB) disruption in migraine vary. Our hypothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowan, Robert P., Gross, Noah B., Sweeney, Melanie D., Sagare, Abhay P., Montagne, Axel, Arakaki, Xianghong, Fonteh, Alfred N., Zlokovic, Berislav V., Pogoda, Janice M., Harrington, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023403/
https://www.ncbi.nlm.nih.gov/pubmed/33724462
http://dx.doi.org/10.1111/head.14088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023403/
https://www.ncbi.nlm.nih.gov/pubmed/33724462
http://dx.doi.org/10.1111/head.14088

Ejemplares similares